195 related articles for article (PubMed ID: 20808813)
1. Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection.
Kimpel J; Braun SE; Qiu G; Wong FE; Conolle M; Schmitz JE; Brendel C; Humeau LM; Dropulic B; Rossi JJ; Berger A; von Laer D; Johnson RP
PLoS One; 2010 Aug; 5(8):e12357. PubMed ID: 20808813
[TBL] [Abstract][Full Text] [Related]
2. A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
Tang X; Jin H; Chen Y; Li L; Zhu Y; Chong H; He Y
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462566
[TBL] [Abstract][Full Text] [Related]
3. Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides.
Zahn RC; Hermann FG; Kim EY; Rett MD; Wolinsky SM; Johnson RP; Villinger F; von Laer D; Schmitz JE
Gene Ther; 2008 Sep; 15(17):1210-22. PubMed ID: 18449216
[TBL] [Abstract][Full Text] [Related]
4. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
[TBL] [Abstract][Full Text] [Related]
5. P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.
Swartz TH; Esposito AM; Durham ND; Hartmann BM; Chen BK
J Virol; 2014 Oct; 88(19):11504-15. PubMed ID: 25031337
[TBL] [Abstract][Full Text] [Related]
6. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
7. Targeting both viral and host determinants of human immunodeficiency virus entry, using a new lentiviral vector coexpressing the T20 fusion inhibitor and a selective CCL5 intrakine.
Petit N; Dorgham K; Levacher B; Burlion A; Gorochov G; Marodon G
Hum Gene Ther Methods; 2014 Aug; 25(4):232-40. PubMed ID: 25045917
[TBL] [Abstract][Full Text] [Related]
8. Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA.
Mautino MR; Morgan RA
Hum Gene Ther; 2002 Jun; 13(9):1027-37. PubMed ID: 12067436
[TBL] [Abstract][Full Text] [Related]
9. Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.
Ledger S; Howe A; Turville S; Aggarwal A; Savkovic B; Ong A; Wolstein O; Boyd M; Millington M; Gorry PR; Murray JM; Symonds G
J Gene Med; 2018 Feb; 20(2-3):e3006. PubMed ID: 29552747
[TBL] [Abstract][Full Text] [Related]
10. Mutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46.
Hermann FG; Egerer L; Brauer F; Gerum C; Schwalbe H; Dietrich U; von Laer D
J Virol; 2009 May; 83(10):4844-53. PubMed ID: 19279116
[TBL] [Abstract][Full Text] [Related]
11. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
[TBL] [Abstract][Full Text] [Related]
12. Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor.
Perez EE; Riley JL; Carroll RG; von Laer D; June CH
Clin Immunol; 2005 Apr; 115(1):26-32. PubMed ID: 15870017
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
Mautino MR; Morgan RA
Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
15. Inducible expression of the deltaNGFr/F12Nef fusion protein as a new tool for anti-human immunodeficiency virus type 1 gene therapy.
Muratori C; Schiavoni I; Melucci-Vigo G; Olivetta E; Santarcangelo AC; Pugliese K; Verani P; Federico M
Hum Gene Ther; 2002 Sep; 13(14):1751-66. PubMed ID: 12396627
[TBL] [Abstract][Full Text] [Related]
16. A novel real-time CTL assay to measure designer T-cell function against HIV Env(+) cells.
MacLean AG; Walker E; Sahu GK; Skowron G; Marx P; von Laer D; Junghans RP; Braun SE
J Med Primatol; 2014 Oct; 43(5):341-8. PubMed ID: 25138734
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer of two entry inhibitors protects CD4⁺ T cell from HIV-1 infection in humanized mice.
Petit NY; Baillou C; Burlion A; Dorgham K; Levacher B; Amiel C; Schneider V; Lemoine FM; Gorochov G; Marodon G
Gene Ther; 2016 Feb; 23(2):144-50. PubMed ID: 26488891
[TBL] [Abstract][Full Text] [Related]
19. Intracellular expression of multimerized antisense TAR-Core RNAs inhibit the replication of human immunodeficiency virus type 1 in human CD4+ T lymphocytes.
Longchuan B; Jiangang Y; Guangwei D; Quanbi Z; Yiming S; Boqin Q
Chin Med Sci J; 1999 Mar; 14(1):13-6. PubMed ID: 12899377
[TBL] [Abstract][Full Text] [Related]
20. Strong
Jin H; Sun Y; Li D; Lin MH; Lor M; Rustanti L; Harrich D
mBio; 2019 Aug; 10(4):. PubMed ID: 31455650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
